Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Preston, N.W.
Stanbridge, T.N.
and
Csizér, Z.
1975.
WHOOPING-COUGH VACCINATION.
The Lancet,
Vol. 305,
Issue. 7915,
p.
1089.
Preston, Noel W.
1976.
Prevalent serotypes ofBordetella pertussisin non-vaccinated communities.
Journal of Hygiene,
Vol. 77,
Issue. 1,
p.
85.
Bassili, W.R
and
Stewart, G.T
1976.
EPIDEMIOLOGICAL EVALUATION OF IMMUNISATION AND OTHER FACTORS IN THE CONTROL OF WHOOPING-COUGH.
The Lancet,
Vol. 307,
Issue. 7957,
p.
471.
Preston, NoelW.
1976.
PROTECTION BY PERTUSSIS VACCINE.
The Lancet,
Vol. 307,
Issue. 7968,
p.
1065.
Cameron, Jack
1976.
Advances in Applied Microbiology Volume 20.
Vol. 20,
Issue. ,
p.
57.
Preston, Noel W.
1979.
Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques.
p.
9.
Preston, Noel W.
1980.
Whooping-cough immunization: Fact and fiction.
Public Health,
Vol. 94,
Issue. 6,
p.
350.
Mangay-Angara, A.
Fulgencio, L.
Casabal, G.
Gudani, L.
Sumpaico, J.
Ocampo, A.
Nagel, J.
Hagenaars, A.M.
van Hemert, P.A.
and
Cohen, H.
1980.
A two-dose schedule for immunization of infants against diphtheria, pertussis and tetanus.
Journal of Biological Standardization,
Vol. 8,
Issue. 2,
p.
87.
Preston, Noel W.
Timewell, Roger M.
and
Carter, Edward J.
1980.
Experimental pertussis infection in the rabbit: Similarities with infection in primates.
Journal of Infection,
Vol. 2,
Issue. 3,
p.
227.
Preston, NoelW.
1983.
PERTUSSIS ANTIBODIES IN VACCINATED CHILDREN.
The Lancet,
Vol. 322,
Issue. 8360,
p.
1197.
Vervloet, D.
1983.
ANAPHYLACTOID REACTIONS TO SUXAMETHONIUM.
The Lancet,
Vol. 322,
Issue. 8360,
p.
1197.
FEERY, BRIAN J.
FINGER, WILLIAM K.
KORTUS, ZYGMUNT
and
JONES, GILLIAN A.
1985.
The incidence and type of reactions to plain and adsorbed DTP vaccines.
Journal of Paediatrics and Child Health,
Vol. 21,
Issue. 2,
p.
91.
Gupta, R.K.
Sharma, Suniti B.
Ahuja, Subhash
and
Saxena, S.N.
1987.
The effect of aluminium phosphate adjuvant on the potency of pertussis vaccine.
Journal of Biological Standardization,
Vol. 15,
Issue. 1,
p.
99.
Blennow, M.
Olin, P.
Granstrom, M.
and
Bernier, R. H
1988.
Protective efficacy of a whole cell pertussis vaccine.
BMJ,
Vol. 296,
Issue. 6636,
p.
1570.
Ashworth, L. A. E.
and
Robinson, A.
1989.
Recent Developments in Prophylactic Immunization.
p.
1.
Gupta, Rajesh Kumar
Saxena, S.N.
Sharma, Suniti B.
and
Ahuja, Subhash
1990.
Immunogenicity of glutaraldehyde inactivated pertussis vaccine.
Vaccine,
Vol. 8,
Issue. 6,
p.
563.
Gupta, Rajesh K.
Relyveld, Edgar H.
Lindblad, Erik B.
Bizzini, Bernard
Ben-Efraim, Shlomo
and
Gupta, Chander Kanta
1993.
Adjuvants — a balance between toxicity and adjuvanticity.
Vaccine,
Vol. 11,
Issue. 3,
p.
293.
Yu, Sylvia
and
Aaskov, John G.
1994.
Development of a candidate vaccine against Ross River virus infection.
Vaccine,
Vol. 12,
Issue. 12,
p.
1118.
Gupta, Rajesh K.
Rost, Bradford E.
Relyveld, Edgar
and
Siber, George R.
1995.
Vaccine Design.
Vol. 6,
Issue. ,
p.
229.